APA (7th ed.) Citation

Ramspott, J. P., Kolmhofer, A., Schabl-Cayron, L., Schredl, P., Emmanuel, K., Bekric, D., . . . Jäger, T. (2026). The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis. Cancers, 18(5), 795. https://doi.org/10.3390/cancers18050795

Chicago Style (17th ed.) Citation

Ramspott, Jan Philipp, et al. "The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis." Cancers 18, no. 5 (2026): 795. https://doi.org/10.3390/cancers18050795.

MLA (9th ed.) Citation

Ramspott, Jan Philipp, et al. "The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis." Cancers, vol. 18, no. 5, 2026, p. 795, https://doi.org/10.3390/cancers18050795.